HRT :: Wyeth loses second hormone therapy drug case
Philadelphia Jury returns verdict that Wyeth’s hormone replacement therapy caused breast cancer and awards $3 million to Ohio woman and her husband.
Evidence
HRT :: Wyeth plans to appeal in Philadelphia Prempro hormone therapy trial
Wyeth (NYSE: WYE) announced today that the jury in the case of Jennie Nelson v. Wyeth, in the Philadelphia Court of Common Pleas, found in favor of the plaintiffs and awarded damages of $3 million. Wyeth plans to appeal.
Sexualization :: Sexualization of girls in media is harmful
A report of the American Psychological Association (APA) released today found evidence that the proliferation of sexualized images of girls and young women in advertising, merchandising, and media is harmful to girls’ self-image and healthy development.
Eating Disorder :: Improving body image key to treating eating disorders
Worrying about weight or a bad hair day is common in our image-obsessed society. But persons with eating disorders spend nearly every waking moment–up to 80 to 90 percent of their day–obsessing about their appearance, say treatment professionals with the Eating Disorders Program at The Menninger Clinic in Houston.
Breast Cancer :: A black and white look at breast cancer mortality
Researchers suggest a reason for racial disparity in breast cancer survival rates. African and African American women are much less likely to survive breast cancer surgery than their white counterparts and far more likely to get the disease before the menopause. Previous research suggests that those who undergo surgery for the disease before the menopause are more prone to relapse.
Multiple Sclerosis :: Pregnancy hormone may offer hope for MS patients
The mystery of why multiple sclerosis (MS) tends to go into remission while women are pregnant may be the secret to overcoming the devastating neurodegenerative disease, according to University of Calgary researchers who have shown that a pregnancy-related hormone is responsible for rebuilding the protective coating around nerve cells.
Breast Cancer :: Tamoxifen yields long-term reduction in breast cancer risk
Tamoxifen offers long-term benefits for breast cancer prevention among women at high risk of the disease, according to two randomized, blinded clinical trials in the February 21 Journal of the National Cancer Institute. The trials found that the breast cancer risk reduction persists long after women stop taking tamoxifen.
Health :: Health professionals would prioritize spending on the young over the old
In prioritizing health-care spending, health professionals rank childhood immunization highest and cancer treatment for smokers lowest, according to a new international survey published in PLoS Medicine.
Memory :: Sense and sensibility in short-term memory
More than three centuries ago, Sir Isaac Newton reflected on the similarities between the sense of hearing and the sense of sight. Newton?s speculations were impossible to test scientifically, until now.
Womb Cancer :: Womb cancer risk linked to waist size
The average British woman, who has a 34 inch waist, is more likely to develop womb cancer than her slimmer sisters.